The peritoneal cavity, which contains the abdominal organs, is a less common but still potential site for breast cancer to ...
A 66-year-old male patient underwent surgery for prostate cancer 4 years ago. His initial prostate-specific antigen (PSA) ...
is no longer detectable on the images taken 2 months after treatment with Bria-OTS™ monotherapy. This 78-year-old woman with metastatic breast cancer (hormone receptor positive, HER2 negative ...
The ReSPECT-LM single-dose escalation trial assessed the safety, tolerability, and potential efficacy of intrathecally ...
Million Private Placement Financing from Existing Investors$2.0 Million Funding Advance from the Cancer Prevention and Research Institute of ...
APCCC Diagnostics annual meeting featured a session on how to monitor metastatic prostate cancer and a presentation by Dr.
Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company" or "Plus Therapeutics"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics ...
Editor's note: The attached video features footage from the 2024 Race for the Cure. Sign up before May 12 ...
Zacks.com on MSN3h
CytomX Gears Up to Report Q4 Earnings: What Should Investors Expect?CytomX Therapeutics CTMX, a clinical-stage oncology company, is slated to report its fourth-quarter 2024 earnings results on ...
AI holds immense promise but also demands a careful, measured approach to yield the greatest benefit—especially for cancer ...
A former university employee accused of accessing a breast cancer study database and changing patient information “hours ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback